In CLL, mutations in NOTCH1, BIRC3 [12], and MYD88 all result in altered NF-kB activity, leading to, in the case of MYD88, elevated levels of cytokines that promote CLL cell survival [13]. The gene discussed is BIRC3; the disease is B-cell chronic lymphocytic leukemia.